The Delhi High Court on Monday, while deciding the plea moved by a senior judge, directed the city government to reimburse him more than Rs 16 lakhs spent by him on the treatment of Covid-19 during the second wave in 2021.
A novel nasal vaccination method has been created by researchers from the Centenary Institute and the University of Sydney that promotes strong lung immunity and protection against the SARS-CoV-2 coronavirus.
Hyderabad (Telangana) [India], May 6 (ANI): As people were suffering from COVID-induced adversities, Chief Minister's Relief Fund in Telengana became quite helpful to the needy.
Seoul [South Korea], March 21 (ANI/Global Economic): S. Korea has become a global production hub to supply generic drugs for Covid-19 treatments to middle- and low-income countries. From vaccines to oral treatments, Korea has been recognized for the production and supply of Covid-19 drugs
New Delhi [India], March 5 (ANI/Target Media): In a landmark development for the treatment of COVID-19, Themis Medicare Ltd. (Themis), a Pharmaceutical company headquartered in Mumbai with a legacy of over 50 years of making new treatment options available, announced the approval of its a
New Delhi [India], February 9 (ANI): Mumbai based innovation-driven global pharma company Glenmark has launched Nitric Oxide Nasal Spray (FabiSpray) in India, in partnership with SaNOtize, for treatment of adult patients suffering from COVID-19.
Augusta (Georgia) [US], January 31 (ANI): A recent study has identified a handful of rare structural gene variants, involved in body processes of some of the sickest patients, like inflammation, which the COVID-19 virus needed, to be successful.
New Delhi [India], January 24 (ANI): India's top virologist, Dr Gagandeep Kang has called the prescription of monoclonal antibody therapy by the doctors in the private hospitals of the country for the treatment of Omicron variant of COVID-19 patients "unethical, immoral and unscientific"
New Delhi [India], January 14 (ANI): As India reported more than 2.64 lakh COVID-19 cases in the last 24 hours, a health expert said most of the patients are recovering with symptomatic treatment and do not require any fancy drugs.
Mumbai (Maharashtra) [India], December 28 (ANI): Drug Controller General of India (DCGI) on Tuesday granted Emergency Use Authorisation (EUA) to Cipla for the launch of Molnupiravir in the country for COVID-19 treatment.
Seoul [South Korea], December 28 (ANI/Global Economic): 'Paxlovid,' the COVID-19 oral treatment developed by a global pharmaceutical company Pfizer, received emergency use authorization from the Ministry of Food and Drug Safety (MFDS) on the 27th. It is expected to be used from the end of Ja
Seoul [South Korea], December 24 (ANI/Global Economic): The Korean government will invest 545.7 billion in the development of COVID-19 treatments and vaccines next year.